137 related articles for article (PubMed ID: 27071454)
1. Clinical guidelines: Clearing murky water - a guideline-based approach to haematuria.
Kaag MG; Raman JD
Nat Rev Urol; 2016 May; 13(5):243-4. PubMed ID: 27071454
[No Abstract] [Full Text] [Related]
2. Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From the American College of Physicians.
Nielsen M; Qaseem A;
Ann Intern Med; 2016 Apr; 164(7):488-97. PubMed ID: 26810935
[TBL] [Abstract][Full Text] [Related]
3. Summaries for Patients. Hematuria as a Marker of Occult Urinary Tract Cancer.
Ann Intern Med; 2016 Apr; 164(7):. PubMed ID: 26811233
[No Abstract] [Full Text] [Related]
4. Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis.
Shinagare AB; Silverman SG; Gershanik EF; Chang SL; Khorasani R
Am J Med; 2014 Jul; 127(7):625-32. PubMed ID: 24565590
[TBL] [Abstract][Full Text] [Related]
5. Non-visible asymptomatic haematuria: a review of the guidelines from the urologist's perspective.
Sountoulides P; Mykoniatis I; Metaxa L
Expert Rev Anticancer Ther; 2017 Mar; 17(3):203-216. PubMed ID: 28116915
[TBL] [Abstract][Full Text] [Related]
6. Macroscopic haematuria--a urological approach.
Yeoh M; Lai NK; Anderson D; Appadurai V
Aust Fam Physician; 2013 Mar; 42(3):123-6. PubMed ID: 23529521
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic evaluation of patients presenting with hematuria: An electronic health record-based study.
Richards KA; Ruiz VL; Murphy DR; Downs TM; Abel EJ; Jarrard DF; Singh H
Urol Oncol; 2018 Mar; 36(3):88.e19-88.e25. PubMed ID: 29169843
[TBL] [Abstract][Full Text] [Related]
8. Investigating asymptomatic invisible haematuria.
Hole B; Whittlestone T; Tomson C
BMJ; 2014 Nov; 349():g6768. PubMed ID: 25404006
[No Abstract] [Full Text] [Related]
9. Evaluation of microscopic hematuria: a critical review and proposed algorithm.
Niemi MA; Cohen RA
Adv Chronic Kidney Dis; 2015 Jul; 22(4):289-96. PubMed ID: 26088073
[TBL] [Abstract][Full Text] [Related]
10. Hematuria.
Peterson LM; Reed HS
Prim Care; 2019 Jun; 46(2):265-273. PubMed ID: 31030828
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
[TBL] [Abstract][Full Text] [Related]
12. Urological recommendations from the National Institute for Health and Care Excellence (NICE) Guideline, June 2015: Suspected cancer: recognition and referral.
Jefferies ER; Brewster SF;
BJU Int; 2016 Jun; 117(6):857-60. PubMed ID: 26473591
[No Abstract] [Full Text] [Related]
13. Guideline of guidelines: asymptomatic microscopic haematuria.
Linder BJ; Bass EJ; Mostafid H; Boorjian SA
BJU Int; 2018 Feb; 121(2):176-183. PubMed ID: 28921833
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of haematuria referrals: two-year data from a single large university hospital in Denmark.
Elmussareh M; Young M; Ordell Sundelin M; Bak-Ipsen CB; Graumann O; Jensen JB
Scand J Urol; 2017 Aug; 51(4):282-289. PubMed ID: 28406341
[TBL] [Abstract][Full Text] [Related]
15. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up.
Buteau A; Seideman CA; Svatek RS; Youssef RF; Chakrabarti G; Reed G; Bhat D; Lotan Y
Urol Oncol; 2014 Feb; 32(2):128-34. PubMed ID: 23153858
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Patients With Asymptomatic Microhematuria.
Kiragu D; Cifu AS
JAMA; 2015 Nov; 314(17):1865-6. PubMed ID: 26529165
[No Abstract] [Full Text] [Related]
17. Hematuria and urologic malignancies.
Lien YH
Am J Med; 2014 Jul; 127(7):570-1. PubMed ID: 24859721
[No Abstract] [Full Text] [Related]
18. Assessment and management of non-visible haematuria in primary care.
Kelly JD; Fawcett DP; Goldberg LC
BMJ; 2009 Jan; 338():a3021. PubMed ID: 19151065
[No Abstract] [Full Text] [Related]
19. Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: prospective study with 13 years' follow-up.
Mishriki SF; Nabi G; Cohen NP
Urology; 2008 Jan; 71(1):13-6. PubMed ID: 18242356
[TBL] [Abstract][Full Text] [Related]
20. Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up.
Edwards TJ; Dickinson AJ; Gosling J; McInerney PD; Natale S; McGrath JS
BJU Int; 2011 Jan; 107(2):247-52. PubMed ID: 20726979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
